WBD 2021

Stop Multiple Sclerosis: World Brain Day 2021

Every five minutes, someone receives the life-altering diagnosis of multiple sclerosis (MS), a neurological disease that affects more than 2.8 million people of all ages worldwide. This World Brain Day is dedicated to raising awareness for MS. Join us on July 22 2021 as we work together to stop MS by diagnosing earlier, providing better access to life-changing treatments, and advocating for improved quality of life for those living with MS and their caregivers.

 

 

 

About World Brain Day

World Brain Day 2021 is dedicated to multiple sclerosis (MS), a neurological disease that affects 2.8 million people of all ages globally. Disease-modifying treatments slow the progression of MS, yet access to these medications is unavailable in many parts of the world. This World Brain Day, let’s work together to stop MS by diagnosing earlier, providing better access to life-changing treatments, and advocating for improved quality of life for those living with MS and their caregivers. Join the World Federation of Neurology (WFN) and the MS International Federation (MSIF) on July 22, 2021, as we share vital information about the signs, symptoms, and treatment of MS.

Key Messages

  • Disability: Multiple sclerosis is a debilitating neurological disease that impacts every aspect of a person’s life, with effects ranging from cognitive impairment to significant physical disability.
  • Prevalence: 2.8 million people of all ages globally are affected by MS, and someone receives this life-altering diagnosis every five minutes.
  • Education: We must work with health care professionals to recognise the signs and symptoms of MS so people can be diagnosed early and effectively treated.
  • Access to Treatment: Disease-modifying treatments slow disease progression, dramatically improving the quality of life for those living with MS, yet access to these medications is unavailable in many parts of the world.
  • Advocacy: We can stop MS by diagnosing earlier, providing better access to life-changing treatments, and advocating for improving the quality of life for those living with MS and their caregivers.

Message from Orly Avitzur, President of the American Academy of Neurology (AAN)

Message from Mary Post, chief executive officer of the American Academy of Neurology (AAN)

WBD 2021 Interviews

 
 

Webinar

On World Brain Day, the WFN and MS International Federation hosted a joint webinar.

An esteemed panel of speakers took part in a webinar discussion on how we can work together to stop MS by diagnosing earlier, providing better access to life-changing treatments, and advocating for improved quality of life for those living with MS and their caregivers.

World Brain Day 2021 Panel

  • Prof. William M. Carroll — President of the World Federation of Neurology​
  • Prof. Tissa Wijeratne — Chair of World Brain Day, World Federation of Neurology​
  • Prof. Wolfgang Grisold​ — Secretary General of the World Federation of Neurology
  • Rachel King — International Evidence Manager of the MS International Federation

 

Taiwan Neurological Society Press Conference

Taiwan Neurology Society (TNS) organized an online press conference on the 22nd of July, 2021 to discuss multiple sclerosis (MS). This online conference attracted many local media to participate which successfully got a lot of public attention to MS in Taiwan.

 

World Brain Day Message From The National Institute of Mental Health and Neurosciences (NIMHANS)

 

MSIF launched the first part of the Atlas of MS (3rd edition), which showed us that there are 2.8 million people around the world living with MS. The atlas highlights the wide disparities and barriers that exist globally in accessing diagnosis, disease modifying therapies and care.

Although, as you know well, there have been many important changes in the health landscape for people with MS in recent years regarding diagnosis and therapy options, unfortunately we continue to see inequalities across and within countries. Some of the key findings from the atlas include:

  • More than three quarters of countries worldwide face issues that prevent early diagnosis of MS
  • In 7 out of 10 countries, people with MS face barriers in accessing disease modifying therapies
  • Therapies for invisible symptoms like fatigue and cognitive impairment are unavailable in 4 out of 10 countries

You can find the full report, and a range of other tools in the hyperlinks provided. MSIF have also produced a new Atlas of MS video - barriers to diagnosis, treatment and care which centres around the key messages shown above. You can watch this on YouTube, Facebook and LinkedIn. Please feel free to share with your networks. The report and video are just available in English at the moment but the Spanish and Arabic versions should be available soon – the other tools are available in all three languages already.

We invite all MS patients and caregivers to share their story of MS on a short video message ( less than 90 seconds) and email the message to wbd2021@wfneurology.org

Interview with Ms Rachel King, MSIF

Official Partners

Prof. Tissa Wijeratne MD FRACP FRSM FAAN FAHA FRCP (Edin) FRCP (London)
Chair, WFN Public Awareness & Advocacy Committee
Senior Neurologist and Director, Stroke Unit, Neuroscience Research Unit, Movement disorders program, Headache program at Western Hospital, Melbourne, Australia

Univ. Prof. Dr. Wolfgang Grisold
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology
Vienna, Austria
WFN Secretary-General

wfn logo.png  Multiple Sclerosis International Federation

Contact

For all enquiries, please contact: wbd2021@wfneurology.org

Mrs Jade Levy
WFN Education Project Coordinator (Jade@wfneurology.org)

Yakkety Yak marketing
Ashley Logan
Yakkety Yak Marketing